• Contact Us
  • New Tenders
  • Register
  • Login

the Supply of a Drug for the Medical Use of Mnn Lidocaine, Magnesium Sulfate, Octreotide, Oseltamivir

RussiaTenders notice for the Supply of a Drug for the Medical Use of Mnn Lidocaine, Magnesium Sulfate, Octreotide, Oseltamivir. The reference ID of the tender is 121860083 and it is closing on 08 Jul 2025.

Tender Details

  • Country: Russia
  • Summary: the Supply of a Drug for the Medical Use of Mnn Lidocaine, Magnesium Sulfate, Octreotide, Oseltamivir
  • RUT Ref No: 121860083
  • Deadline: 08 Jul 2025
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 0360300136325000173
  • Purchaser's Detail:
  • Purchaser : STATE HEALTHCARE INSTITUTION OF THE SARATOV REGION "KRASNOARMEYSKAYA DISTRICT HOSPITAL" (TIN 6442003697)
    Guz from Krasnoarmeyskaya RB
    FULL NAME: Podatnikova Julia Yuryevna
    Phone: 7-845-5021283
    Email :krasncrb@mail.ru

  • Description:
  • The supply of a drug for the medical use of MNN Lidocaine, magnesium sulfate, octreotide, oseltamivir
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us